UniTI-101

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameUniTI-101

Drug Alias NameCSF-1R x CCR2 bispecific antibody (Elstar Therapeutics)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionC-C chemokine receptor type 2 antagonistsMacrophage Colony Stimulating Factor 1 inhibitors

TargetsMacrophage Colony Stimulating Factor 1C-C chemokine receptor type 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMarengo Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMarengo Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A